# Exploratory Randomized, Controlled, Dose-response Study on the Impact of Nicotine From Five Variants of a Nicotine Tablet (NICOTINE TABLET) on Attention

> **NCT07408180** · NA · COMPLETED · sponsor: **Philip Morris Products S.A.** · enrollment: 40 (actual)

## Conditions studied

- Attention

## Interventions

- **OTHER:** NICOTINE TABLET-0mg
- **OTHER:** NICOTINE TABLET-0.5mg
- **OTHER:** NICOTINE TABLET-1.0mg
- **OTHER:** NICOTINE TABLET-1.5mg
- **OTHER:** NICOTINE TABLET-2.0mg

## Key facts

- **NCT ID:** NCT07408180
- **Lead sponsor:** Philip Morris Products S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-10-28
- **Primary completion:** 2026-03-16
- **Final completion:** 2026-04-23
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2026-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07408180

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07408180, "Exploratory Randomized, Controlled, Dose-response Study on the Impact of Nicotine From Five Variants of a Nicotine Tablet (NICOTINE TABLET) on Attention". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07408180. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*